Delivery Order SPE2DB24D9314-SPE2DB25FKRLP
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on April 10, 2025, with an ultimate completion date of May 1, 2025, represents a tactical procurement action without set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $26,038.50 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery at its Illinois location with an ultimate completion date of October 15, 2025. This award was made without a set-aside designation, allowing the company to compete directly in the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for ultimate completion on September 29, 2025, and represents a continuation of the company's ongoing pharmaceutical supply...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will deliver the contraceptive devices to support federal healthcare needs. This delivery order was issued without a set-aside designation and is scheduled for completion by September 3, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg contraceptive systems, with an ultimate completion date of October 6, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group, a woman-owned small business based in Park Ridge, Illinois, will perform the work at its primary location. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025, and was awarded on September 12, 2025. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order was issued on April 8, 2025, with an ultimate completion date of April 29, 2025, and represents no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- SPE2DB24D9314Indefinite Delivery Contract
- SPE2DB24D9314-SPE2DB25FKRLPDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by July 14, 2025, and represents a direct procurement from the vendor's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle enabling the agency to issue firm fixed-price orders for pharmaceutical products supporting Department of Defense healthcare facilities. This award reflects DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to military health facilities nationwide. The company's robust portfolio with the DLA encompasses diverse pharmaceutical products spanning contraceptive devices, oncology treatments, vaccines, and specialty medications. The SPE2DB indefinite delivery contract, valid through November 2026, provides the DLA with flexible procurement mechanisms to fulfill ongoing medical supply requirements across its global healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/20/25 |